Last update: July 21, 2017
Minimal risk for breastfeeding and infant.
Corticosteroids are commonly found in breast milk at an average concentration of 6-33 micrograms / liter.
When used topically, in inhalation, intra-articular or enema: Its low absorption through the skin, nasal or bronchial mucosa, joint or colon, makes it unlikely a excretion into breast milk in significant amount. It has been published a case of decreased milk production after intra-articular injection of corticosteroids.
Should you be treated for eczema or dermatitis of the nipple, choose the least potent corticosteroid, make sure to apply it just after the meal to make sure it has been absorbed before the next meal, if necessary remove excess of cream with a gauze and do not used it for more than a week. Mineralocorticoid toxicity has occurred in an infant after continuous application of a corticosteroid in the nipple.
Avoid application creams, gels and other paraffin-containing products on the nipple, to avoid ingestion by the infant.
The American Academy Pediatrics states that systemic corticoid treatment is compatible with breastfeeding, recommending the use of prednisone or prednisolone because it is barely excreted in the breast milk.
WHO List of Essential Medicines 2002: classifies it as compatible with breastfeeding.
For a more detailed information, please check the specific profile of each steroid separately.
We do not have alternatives for (Corticoids) since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.